- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Mosaic quadrivalent influenza vaccine single nanoparticle characterization ; volume:14 ; number:1 ; day:24 ; month:2 ; year:2024 ; pages:1-12 ; date:12.2024
Scientific reports ; 14, Heft 1 (24.2.2024), 1-12, 12.2024
- Urheber
-
Yang, Rong Sylvie
Traver, Maria
Barefoot, Nathan
Stephens, Tyler
Alabanza, Casper
Manzella-Lapeira, Javier
Zou, Guozhang
Wolff, Jeremy
Li, Yile
Resto, Melissa
Shadrick, William
Yang, Yanhong
Ivleva, Vera B.
Tsybovsky, Yaroslav
Carlton, Kevin
Brzostowski, Joseph
Gall, Jason G.
Lei, Q. Paula
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-54876-2
- URN
-
urn:nbn:de:101:1-2405020900018.908566894473
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yang, Rong Sylvie
- Traver, Maria
- Barefoot, Nathan
- Stephens, Tyler
- Alabanza, Casper
- Manzella-Lapeira, Javier
- Zou, Guozhang
- Wolff, Jeremy
- Li, Yile
- Resto, Melissa
- Shadrick, William
- Yang, Yanhong
- Ivleva, Vera B.
- Tsybovsky, Yaroslav
- Carlton, Kevin
- Brzostowski, Joseph
- Gall, Jason G.
- Lei, Q. Paula
- SpringerLink (Online service)
Ähnliche Objekte (12)
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Adjuvanted influenza vaccine dynamics
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Physics Models of Plasmonics: Single Nanoparticle, Complex Single Nanoparticle, Nanodimer, and Single Nanoparticle over Metallic Thin Film
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Generation and evaluation of universal influenza vaccine candidates
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Adjuvanted influenza vaccine dynamics
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Physics Models of Plasmonics: Single Nanoparticle, Complex Single Nanoparticle, Nanodimer, and Single Nanoparticle over Metallic Thin Film
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA
Generation and evaluation of universal influenza vaccine candidates
A mosaic influenza virus-like particles vaccine provides broad humoral and cellular immune responses against influenza A viruses
Preclinical evaluation of a universal inactivated influenza B vaccine based on the mosaic hemagglutinin-approach
Influenza Vaccine Effectiveness and Progress Towards a Universal Influenza Vaccine
Adjuvanted influenza vaccine dynamics
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Physics Models of Plasmonics: Single Nanoparticle, Complex Single Nanoparticle, Nanodimer, and Single Nanoparticle over Metallic Thin Film
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Cost-effectiveness analysis of quadrivalent influenza vaccine versus trivalent influenza vaccine for elderly in Hong Kong
Multivalent Peptide–Nanoparticle Conjugates for Influenza‐Virus Inhibition
Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
Improved influenza vaccine responses after expression of multiple viral glycoproteins from a single mRNA